# Ayogo Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ayogo-health

- Industry: Healthcare IT
- Headquarters: Vancouver, Canada
- Website: www.ayogo.com
- Total disclosed funding: $7.8M
- Latest round: Series B (May 1, 2020)
- Investors on record: 5

## About

Ayogo Health Inc. specializes in digital health solutions that empower patients to engage with their healthcare journeys through innovative technology and personalized support.Founded in 2011, Ayogo Health Inc. is based in Vancouver, Canada, and focuses on creating digital health platforms that enhance patient engagement. The company has secured funding through two notable deals, the most recent being a Series B round in May 2020, during which it raised CAD 7.5 million from investors including Baxter International, Inc. and Merck Global Health Innovation Fund. CEO Michael Fergusson leads the company, which has aimed to refine its business strategy and expand its offerings in the digital health sector.Ayogo Health Inc. provides digital health solutions that facilitate patient engagement by offering personalized tools and resources. These services are tailored to the needs of healthcare providers and patients, ensuring that individuals receive the support they require for better health outcomes. By combining technology with patient-centric strategies, Ayogo aims to enhance the management of chronic diseases and improve patient adherence to treatment plans.Ayogo Health Inc. generates revenue through partnerships with healthcare organizations and technology licensing agreements. Its subscription-based model provides healthcare providers access to innovative digital tools and platforms designed to improve patient engagement and health management. The company focuses on delivering tailored solutions that meet the demands of the changing healthcare landscape.In the coming years, Ayogo Health Inc. plans to develop new digital health products aimed at further enhancing patient engagement and support. The company is targeting expansion into additional markets, with specific focus on North America and Europe by the end of 2022. The CAD 7.5 million raised in its Series B funding round will be utilized to advance product development and support marketing efforts in these new regions, ensuring that Ayogo continues to meet the needs of healthcare providers and patients alike.

## Funding rounds

- Series B, May 1, 2020, $5.3M — Excel Venture Management, Merck Global Health Innovation Fund, Baxter International, Inc., 7wireVentures, MEDTEQ+
- Series A, Apr 7, 2015, $2.5M — Excel Venture Management, Merck Global Health Innovation Fund, 7wireVentures

## Investors

- Excel Venture Management (https://capitalatlas.ai/funds/excel-venture-management) — Series A, Series B
- Merck Global Health Innovation Fund (https://capitalatlas.ai/funds/merck-global-health-innovation-fund) — Series A, Series B
- 7wireVentures (https://capitalatlas.ai/funds/7wireventures) — Series A, Series B
- Baxter International, Inc. — Series B
- MEDTEQ+ — Series B